SEATTLE| Feb. 9, 2017

FOR IMMEDIATE RELEASE: Seattle | Feb. 9, 2017 : Richard Lautch, a senior finance leader who most recently served as an executive with Starbucks Coffee Co., has joined the Board of Directors of IDRI (Infectious Disease Research Institute) and is a member of the board’s finance committee.

“We are fortunate to have a board that includes a breadth of experience and accomplishment in scientific and international affairs, from both industry and academia,” said Steven G. Reed, Ph.D., IDRI President, CEO and Founder. “As we expand our board to broaden expertise in key areas that will support IDRI’s continued growth, we are pleased to welcome Richard who brings an exceptional depth of knowledge from the financial perspective.”

Richard LautchA financial leader with experience during rapid company growth and change, Lautch had a 15-year career with Starbucks. Most recently, he served as Vice President Finance, Treasurer – Finance Administration, where he played an instrumental role in growing revenues from less than $2 billion to more than $15 billion with a global footprint that expanded from 4 to 64 countries. While at Starbucks, Lautch played key roles in capital structure and financing, financial planning and analysis, investment strategy, relationship management and impact investing. He also served in a variety of leadership roles ranging from being a member of Starbucks’ Capital Committee to serving as chairman of Starbucks Card Europe Ltd.

Prior to joining Starbucks in 1999, Lautch spent 12 years in investment banking research and trading roles working with global equity, bond and currency markets while at Banco Santander,  BNP Paribas and National Westminster Bank.

“Some of my most enjoyable and rewarding work has been in supporting global development,” said Lautch. “Sadly, the poorest populations often struggle to develop because of basic health problems. The work that IDRI is doing to address some of the most damaging diseases affecting lower income countries could dramatically improve the lives of their people. The forward thinking and collaborative culture at IDRI opens up many opportunities for expanding its impact. I am honored to join such a wonderful team and look forward to supporting its future growth.”

Lautch holds a degree in electrical and electronic engineering from the University of Bath in England. He serves on the finance committees for The Grameen Foundation and the Washington Chapter of the Nature Conservancy.

About IDRI

As a nonprofit global health organization, IDRI (Infectious Disease Research Institute) takes a comprehensive approach to combat infectious diseases, combining the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines. Founded in 1993, IDRI has 125 employees headquartered in Seattle with nearly 100 partners/collaborators around the world. For more information, visit


IDRI: Lee Schoentrup | 206.858.6064 |